ClinConnect ClinConnect Logo
Search / Trial NCT05202080

Effect of a Pre-operative Internet-based Educational Video on Post Operative Opioid Consumption

Launched by SUNNYBROOK HEALTH SCIENCES CENTRE · Jan 7, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether a 30-minute online educational video can help patients use fewer opioids after hip or knee replacement surgery. The video will provide important information on how to safely use both opioid and non-opioid pain medications, as well as techniques and exercises to manage pain better. The goal is to empower patients to take control of their pain management, reducing the risk of opioid addiction, which is a significant concern in today’s healthcare environment.

To participate in this trial, you need to be an adult over 18 years old, scheduled for elective hip or knee surgery, and able to speak English with access to the internet. You should also have a certain level of cognitive ability to understand the video content, which will be assessed during screening. If you join the study, you will watch the video before your surgery, and researchers will check how much pain medication you use after the procedure and ask for any unused opioids back at your follow-up appointment in six weeks. This trial aims to help improve pain management practices and ensure safer recovery experiences for patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be adults (\> 18 years of age) undergoing knee or hip arthroplasty.
  • Patients will be ASA 1-3 undergoing elective surgery.
  • English speaking patients with internet and computer access at home will be included.
  • Patients with pre-existing psychological conditions who receive either pharmaceutical or talk-based therapy will be included.
  • Patients must meet a minimum cognitive capacity to understand the instructions for the Opioid Counseling and Pain Coping Skills presentation. This will be assessed by the administration of the Montreal Cognitive Assessment during screening (MoCA), whereby a minimum score of 18 will be required to meet inclusion into the study.
  • Exclusion Criteria:
  • Significant cognitive impairment.
  • Chronic pain, long-term opioid therapy
  • Renal replacement therapy
  • Standing opioid requirements
  • Neuropathic pain
  • Fractures requiring emergency surgery
  • End stage cardiac or respiratory disease
  • Severe hepatic dysfunction,
  • Patients with severe psychiatric disorders
  • Vision loss
  • Allergy to local anesthesia.
  • Patients who refuse to consent to neuraxial anesthesia and/or peripheral nerve blocks will also be excluded.

About Sunnybrook Health Sciences Centre

Sunnybrook Health Sciences Centre is a leading academic health science organization located in Toronto, Canada, renowned for its commitment to advancing patient care through innovative research and education. As a prominent clinical trial sponsor, Sunnybrook integrates cutting-edge medical research with clinical practice, focusing on a wide range of health disciplines, including cancer care, trauma, and cardiovascular health. The center collaborates with various stakeholders, including academic institutions, healthcare providers, and industry partners, to facilitate the development of novel therapies and improve health outcomes. With a robust infrastructure and a dedicated team of researchers and clinicians, Sunnybrook plays a pivotal role in translating scientific advancements into tangible benefits for patients.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials